Skip to main content
IDXG logo

IDXG · Interpace Biosciences, Inc.

Track IDXG — free
$3.25 At close · Feb 25
Market Cap
$42.19M
Shares
5.54M

Weekly off-exchange (dark pool / OTC) trading volume reported to FINRA under its OTC/ATS Transparency data. ATS volume is executed on alternating trading systems (dark pools); non-ATS OTC is other over-the-counter dealer volume. The off-exchange share is total off-exchange volume as a percentage of consolidated weekly trading volume for the same Monday–Friday week.

Off-Exchange Volume History

Week Start ATS Volume Non-ATS OTC Volume Total Off-Exchange % of FINRA Weekly Volume
2026-07-13 0 9,710 9,710
2026-07-06 1,387 7,982 9,369
2026-06-29 12,771 9,097 21,868
2026-06-22 9,543 31,001 40,544
2026-06-15 0 15,847 15,847
2026-06-08 4,400 18,637 23,037
2026-06-01 4,008 33,148 37,156
2026-05-25 9,247 7,799 17,046
2026-05-18 13,300 46,764 60,064
2026-05-11 1,936 12,700 14,636
2026-05-04 43,412 26,124 69,536
2026-04-27 1,504 26,274 27,778
2026-04-20 12 14,650 14,662
2026-04-13 2,310 26,866 29,176
2026-04-06 3,724 34,781 38,505
2026-03-30 11,722 22,710 34,432
2026-03-23 5 938 943
2026-03-16 7,222 11,022 18,244
2026-03-09 3,102 18,083 21,185
2026-03-02 10,552 30,377 40,929
2026-02-23 2,050 6,845 8,895
2026-02-16 5,978 14,119 20,097
2026-02-09 12,798 44,391 57,189
2026-02-02 3,512 30,302 33,814
2026-01-26 11,605 42,727 54,332
2026-01-19 42,058 119,779 161,837
2026-01-12 6,601 26,946 33,547
2026-01-05 4,394 15,947 20,341
2025-12-29 11,011 29,709 40,720
2025-12-22 14,116 40,487 54,603
2025-12-15 11,212 26,340 37,552
2025-12-08 13,500 102,977 116,477
2025-12-01 4,010 19,141 23,151
2025-11-24 185 21,044 21,229
2025-11-17 7,500 77,913 85,413
2025-11-10 26,990 36,743 63,733
2025-11-03 19,883 25,154 45,037
2025-10-27 17,558 65,654 83,212
2025-10-20 4,893 18,257 23,150
2025-10-13 485 27,857 28,342
2025-10-06 4,839 21,662 26,501
2025-09-29 2,463 30,223 32,686
2025-09-22 0 19,000 19,000
2025-09-15 0 7,913 7,913
2025-09-08 0 29,882 29,882
2025-09-01 14,859 42,584 57,443
Showing 1–46 of 46 weeks
Key facts CIK 1054102 CUSIP 46062X303 Visit website Investor relations